Fmoc-L-phenylglycine

Fmoc-L-phenylglycine is an Fmoc-protected L-amino acid derivative in which the amino group is masked by a 9H-fluorenylmethyloxycarbonyl (Fmoc) protecting group while the carboxylic acid remains available for peptide coupling. The molecule features the L-stereogenic center characteristic of phenylglycine, linking the α-amino acid backbone to a benzyl-like side chain (phenylmethyl), which provides hydrophobic, aromatic recognition elements in peptide and peptidomimetic scaffolds. The Fmoc carbamate is stable to many coupling conditions yet can be removed under base to reveal the free amine for stepwise solid-phase or solution-phase synthesis. The combination of a chiral amino acid core and an aromatic side chain makes Fmoc-L-phenylglycine a practical chiral building block for constructing amide-linked sequences and for generating downstream derivatives via controlled functional group transformations.

1. Peptide Synthesis

Fmoc-L-phenylglycine is used in peptide synthesis workflows where Fmoc protection supports iterative N-terminal deprotection and coupling cycles. The amino acid backbone provides a carboxylic acid suitable for standard peptide coupling chemistry, while the phenylmethyl side chain contributes conformational and hydrophobic effects that can influence folding and binding profiles of peptide sequences. The L-configuration at the α-carbon enables stereochemically defined incorporation into peptide chains, supporting reproducible structure-function studies and sequence analog generation. Stepwise assembly of protected amino acid residues using Fmoc chemistry enables preparation of peptide building blocks for research-grade libraries and method development in peptide science.

2. Peptidomimetics And SAR Studies

Fmoc-L-phenylglycine is applied in peptidomimetic construction and structure-activity relationship studies where phenylglycine residues can modulate backbone geometry and aromatic side-chain presentation. The Fmoc-protected amine allows controlled incorporation into constrained analogs, while the free carboxyl group enables formation of amide bonds that preserve stereochemical integrity during library synthesis. The phenylmethyl side chain can be further functionalized after peptide assembly or during intermediate preparation, supporting SAR-driven exploration of hydrophobic contacts and steric effects. Downstream derivatization of peptide fragments derived from Fmoc-L-phenylglycine can generate non-natural analogs for comparative binding and stability investigations in biochemical research.

3. Chiral Amino Acid Intermediate

Fmoc-L-phenylglycine functions as a chiral amino acid intermediate for stereoselective synthesis of functionalized fragments used in medicinal chemistry and fine chemical production. The preserved L-stereocenter and the protected carbamate provide a handle for sequential transformations, including conversion of the carboxyl group into activated esters or amides and controlled deprotection of the Fmoc group when a free amine is required. The aromatic side chain enables downstream aromatic substitution strategies or incorporation into heteroatom-containing frameworks through amide-forming steps. The material's defined stereochemistry supports reproducible generation of chiral intermediates for downstream synthesis of complex molecules and peptide-derived scaffolds.

4. Chemical Biology Probes

Fmoc-L-phenylglycine is utilized in chemical biology research for preparing peptide-based probes and conjugation-ready fragments that require a defined hydrophobic/aromatic motif. The Fmoc-protected amine supports orderly assembly of probe sequences, while the carboxyl functionality enables attachment to linkers or formation of amide-linked reporter conjugates after deprotection. The phenylmethyl side chain can serve as a recognition element in affinity reagents, and the stereogenic center helps maintain consistent spatial presentation of the backbone. Probe synthesis based on Fmoc-L-phenylglycine can feed into downstream labeling strategies and analytical characterization of biomolecular interactions.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-phenylglycine is relevant to pharmaceutical manufacturing and process chemistry as an Fmoc-protected amino acid building block for producing peptide intermediates under controlled protecting-group logic. The Fmoc carbamate provides a robust N-protection strategy compatible with peptide coupling operations, and base-mediated Fmoc removal enables predictable generation of reactive amine termini during manufacturing-scale sequence assembly. The presence of an aromatic phenylmethyl side chain supports incorporation into hydrophobic peptide segments that may be used in processable intermediate forms for further conversion to larger active or investigational peptide structures. Industrial peptide intermediate preparation benefits from stereodefined amino acid inputs such as the L-phenylglycine residue, supporting consistent downstream synthesis and purification workflows.

6. Side-Chain Functionalization

Fmoc-L-phenylglycine is suitable for side-chain functionalization strategies where the phenylmethyl substituent can be leveraged for post-assembly modifications or intermediate derivatization. The protected amino group and carboxylic acid allow selective chemistry at each functional site, enabling controlled formation of amide derivatives during peptide or fragment synthesis and later transformation of the aromatic-bearing side chain through electrophilic aromatic substitution, oxidation-state adjustments, or linker installation. The stereogenic center remains intact during many derivatization sequences, supporting generation of stereochemically consistent analogs for comparative studies. Functionalized derivatives derived from Fmoc-L-phenylglycine can serve as building blocks for specialty chemical production, including peptidomimetic fragments and aromatic side-chain-containing intermediates.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy